|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 9/14 | (2006.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 15/10 | (2006.01) | ||
| B01J 19/00 | (2006.01) |
| (11) | Number of the document | 1200092 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00952371.3 |
| Date of filing the European patent application | 2000-08-01 | |
| (97) | Date of publication of the European application | 2002-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2004-04-21 |
| (46) | Date of publication of the claims translation | 2004-06-25 |
| (86) | Number | PCT/US2000/020981 |
| Date | 2000-08-01 |
| (87) | Number | WO 2001/008688 |
| Date | 2001-02-08 |
| (30) | Number | Date | Country code |
| 147048 P | 1999-08-03 | US |
| (72) |
ANDERSON, Neil, R., US
HARTAUER, Kerry, J., US
KRAL, Martha, A., US
STEPHENSON, Gregory, A., US
|
| (73) |
ICOS CORPORATION,
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Tatjana STERLINA,
UAB "Intels", Naugarduko g. 32/2, LT-03225 Vilnius,
LT
|
| (54) | ß-karbolino vaistiniai produktai |
| BETA-CARBOLINE DRUG PRODUCTS |
| Payment date | Validity (years) | Amount | |
| 2019-07-30 | 20 | 347.00 EUR |